October 4, 2010

Human Genome Sciences and Novartis have decided not to further develop an investigative biologic treatment...

October 3, 2010

The Food and Drug Administration has awarded almost $3 million for tuberculosis research, the agency...

September 30, 2010

Data published in the latest issue of medical journal The Lancet showed that a recently...

September 29, 2010

The biotech division of Johnson & Johnson is hoping to expand the use of a...

September 28, 2010

The drug market for Crohn's disease treatments will see moderate growth over the next decade,...

September 28, 2010

Keryx has begun its phase-3 clinicial trial of a drug designed to treat elevated serum...

September 28, 2010

While biosimilars promise to provide therapies for a wide range of diseases, their biggest fans...

September 28, 2010

The subject of specialty pharmacy reached a whole new level of nuance as a wide...

September 27, 2010

The market for hypertension drugs will drop by $3 billion by the end of the...

September 27, 2010

Pfizer has halted a late-stage trial of a drug therapy in men with prostate cancer,...

September 27, 2010

The Hart-Scott-Rodino waiting period for Bristol-Myers Squibb’s acquisition of Seattle-based biotech company ZymoGenetics has expired,...

September 26, 2010

An investigational drug made by Johnson & Johnson for treating pain showed significant reduction in...

September 22, 2010

The Food and Drug Administration has accepted AstraZeneca’s regulatory application for an investigational cancer drug,...

September 21, 2010

Swiss drug maker Novartis said its investigational drug is the first to show promise in...

September 20, 2010

A Food and Drug Administration advisory committee has recommended approval of a drug for patients...

September 19, 2010

Biotech company Genentech has amended its application to the Food and Drug Administration seeking an...

September 16, 2010

Boehringer Ingelheim has started a late-stage clinical trial of a drug for treating breast cancer,...

September 16, 2010

Emergent BioSolutions has landed a $51 million contract from the Department of Health and Human...

September 16, 2010

The Food and Drug Administration has accepted for review a regulatory approval application for a...

September 16, 2010

An advisory committee of the Food and Drug Administration has given a thumbs-down to a...

September 13, 2010

Biotech companies Seattle Genetics and Genmab will collaborate to develop antibody treatments for cancer, the...

September 12, 2010

The Food and Drug Administration has accepted a regulatory approval application for a flu vaccine...

September 12, 2010

The Food and Drug Administration did not completely withdraw from the market a drug used...

September 12, 2010

An investigational treatment for HIV by Gilead Sciences that combines four drugs in one tablet...